Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Zipp

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
Neurogenetics|November 19, 2011
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sampleChristina M Lill, Brit-Maren M Schjeide, Denis A Akkad, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
PML risk stratification using anti-JCV antibody index and L-selectinNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.
Nature Communications|December 18, 2019
IL-17<sup>+</sup> CD8<sup>+</sup> T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosisChristina Lückel, Felix Picard, Hartmann Raifer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalban, Ralf Gold, Alan J Thompson, et al.
Nature Immunology|January 20, 2015
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivoAlexander Ulges, Matthias Klein, Sebastian Reuter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Is <i>APOE</i> ε4 associated with cognitive performance in early MS?Sinah Engel, Christiane Graetz, Anke Salmen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohortPhilip Lennart Poser, Barbara Gisevius, Marianne Tokic, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
Neurogenetics|November 19, 2011
Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sampleChristina M Lill, Brit-Maren M Schjeide, Denis A Akkad, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2020
Genetic determinants of the humoral immune response in MSChristiane Gasperi, Till F M Andlauer, Ana Keating, et al.
Der Nervenarzt|July 13, 2019
[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]Stefan Bittner, Sinah Engel, Christoph Lange, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
PML risk stratification using anti-JCV antibody index and L-selectinNicholas Schwab, Tilman Schneider-Hohendorf, Béatrice Pignolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 2022
Association of obesity with disease outcome in multiple sclerosisIsabel Lutfullin, Maria Eveslage, Stefan Bittner, et al.
Nature Communications|December 18, 2019
IL-17<sup>+</sup> CD8<sup>+</sup> T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosisChristina Lückel, Felix Picard, Hartmann Raifer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2018
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosisXavier Montalban, Ralf Gold, Alan J Thompson, et al.
Nature Immunology|January 20, 2015
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivoAlexander Ulges, Matthias Klein, Sebastian Reuter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 3, 2020
Is <i>APOE</i> ε4 associated with cognitive performance in early MS?Sinah Engel, Christiane Graetz, Anke Salmen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohortPhilip Lennart Poser, Barbara Gisevius, Marianne Tokic, et al.
Pageof 32